Latest Entry: American Pravda and New York's Sixth Crime Family     Latest Comments: Talk Back Here

« OB/GYN Panel Reviewing Alaska Abortion Web Site Agrees To Include Material on Abortion-Breast Cancer Link, Fetal Pain | Main | Scientists Find Key Player in Cancer's Spread »

May 4, 2005

Alzheimer's Cognitive Decline Slowed In Gene Therapy Patients

Topics: Medicine

PET scans and cognitive tests have suggested that Alzheimer's disease patients with genetically modified tissue inserted directly into their brains show a reduction in the rate of cognitive decline and increased metabolic activity in the brain, according to a study published in the April 24, 2005 online issue of the journal Nature Medicine by researchers at the University of California, San Diego (UCSD) School of Medicine.  More ...

Based on the positive findings of this Phase I trial, a new Phase I/II study using direct NGF gene delivery to the brain, thereby eliminating the need for grafting cells, is currently underway at Rush University Medical Center in Chicago, sponsored by the San Diego biotechnology company Ceregene, Inc. The Chicago trial is under the direction of David Bennett, M.D., director of the Rush University Alzheimer's Disease Center, and Zoe Arvanitakis, M.D., a Rush neurologist.

Posted by Hyscience at May 4, 2005 11:01 AM

Articles Related to Medicine: